Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2018-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd63d0fd7fe02cc1c26ff9d9686f036b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ff0dfe7def81aa80f89bba01ffb9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9d614067e2b34a0a0ac0ebf55a78a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_523f4a07260a50d472dc1c0670d75cf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31ce8d004ff5d96882f686cbc2432a81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfee82999d07236647b2bfbf5163bfa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f1e697155fc752ab353e3ceb4c96a0e |
publicationDate |
2021-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MA-51020-A |
titleOfInvention |
IMIDAZOPYRIDIN COMPOUNDS AND THEIR USE AS A MEDICINAL PRODUCT |
priorityDate |
2017-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |